0022.3YW90 $3.00 + .OO IFS1990 Pergamon Pros plc
J ~sych,ol. Rex. Vol. 24, Suppl. 2, pp. 121-127, 1990 Printed m Great Britain.
BENZODIAZEPINES
AND ALCOHOL
MARKKU I. LJNNOILA NationalInstitute on Alcohol Abuse and Alcoholism, Bethesda. MD 20X92. U.S.A. Summary-The frequency and quantity of alcohol consumption is a major consideration in patients who need treatment with benzodiazepinej. Alcohol affects the GABA-ben/.odiarepine-chloride ionophore complex and has an agonist-like action. Thuh, additive interactions should be expected from combining alcohol with benzodiaaepines. Furthermore, alcohol has clinically meaningful anxmlytic efficacy. and many anxious patients may take advantage of that fact. Therefore, co-administration of alcohol and henrodiazepines is to be expected in an anxious patient receiving benrodiaLepmea who doe\ not totally abstain from alcohol. Thi\ article reviews three clmically relevant isues concerning benLodiazepines and alcohol: (I) interactions of ben/odiarepinea with social drinking in patients taking benrodiaLepines for indications unrelated to alcoholism: (2) use of henzodiaLepines in treatment of alcohol withdrawal: and (3) use of hen7odiaxpines m patients with alcohol dependence.
INTRODUCTION SHORT review elucidates three clinically relevant issues concerning benzodiazepines and alcohol: 1. Interactions of benzodiazepines with socially used quantities of alcohol in patients taking benzodiazepines for indications unrelated to alcoholism; 2. Benzodiazepines in treatment of alcohol withdrawal: and 3. Use of benzodiazepines in patients with alcohol dependence. This review is derived from six recent overviews written by investigators from Laboratory of Clinical Studies, DICBR, National Institute on Alcohol Abuse and Alcoholism (LINNOILA, 1983; LINNOILA, 1984a; LINNOILA, 1984b; LINNOILA, 1987: NUTT et ul., 1989). These overviews should be consulted for a complete list of references. THIS
INTERACTIONS
OF BENZODIAZEPINES
WITH
ALCOHOL
Despite the fact that recent studies have documented superior long-term efficacy of antidepressants over benzodiazepines in the treatment of anxiety disorders. benzodiazepines still are widely prescribed for these disorders. Alcohol, a widely used social emollient with a non-specific mechanism of action, affects the GABA-benzodiazepine-chloride ionophore complex. Its net effect is an agonist-like action. Thus, additive interactions are to be expected from combining alcohol with benzodiazepines. Furthermore, alcohol acutely has clinically meaningful anxiolytic efficacy, and many anxious patients have taken advantage of this fact. Therefore, co-administration of alcohol and benzodiazepines is to be expected in any anxious
Address Alcoholism,
correspondence LCS.
DICBR,
to Markku Building
Linnoila. IO, Room
M.D., 3Bl9.9000
Ph.D.,
National
Rockville,
Institute MD
20892.
on Alcohol U.S.A.
Abuse
and
patient
receiving
clinician’s
duty
evaluation.
This
insomnia.
benzodiazepines to carefully is particularly
needs treatment patient’s
frequency
amounts
of alcohol
benzodiazepines relatively
low propensity
the market
in the United
be buspirone. administered
in patients
a relevant
of alcohol
with
alcohol.
patient
disorders.
and they should
to produce
It is the
presenting
for
depression.
and
a non-benzodiat.epine
anxiolytic
a benzodiazepine
Patients
warned
about
who often
additive
be treated with
adverse
SLICK
fact in choosing
Two
adverse
such drugs
oxaLepam.
and
A useful
that is free of additive
even
effects
of
that has a currently
on
alternative
may
adverse effects
Because these three drug\ have not been shown
the treatment of panic attacks. they should
is the
COI~SLI~W
a ben/odiazepine
interactions.
States are chlordiazepoxide
with alcohol.
from
of any
anxiety
consumption.
have to be clearly
and alcohol.
abstain
habits
that a patient i\ not dependent on or abusing alcohol and
benzodiazepines,
and quantity
not totally
are common to patients with alcohol dependence.
has determined
with
does
the drinking
important
because these complaints
Once the physician
small
who
explore
when
to be efficacious
not be used when panic symptoms
in
are a part of a
patient’s complaints.
BENZOI~IAZEPINES
Two
pathophysiological
Ih’ THt
‘f’KEATMf’.NT
characteristics
hypothalamic-pituitary-adrenocortical
Of= ALCOHOL.
of alcohol
overactivity.
WITHIIKAWAI
withdrawal.
respond
well
noradrenergic
to benzodiaLepines,
~lncl
u hich
are the current treatment of choice of this condition. Controlled such
studies
have demonstrated
as chlorpromazine
benzodiaLepines tremens.
can also
Although
effective
pharmacological
currently
situations.
intervention.
of ethanol
use in the United
in moderate withdrawal
Oral diazepam
which time a loading dose should be instituted,
or the symptoms
with
in severe withdrawal
procedure
diaLepam
initially
IO mg every
sedated. If withdrawal re-evaluated symptoms
for
dosing. this
symptoms
illnesses.
additional
Careful
doses
eliminatin,
permits
a withdrawal
hourly
six
20
nrg.
01.
dons.
evaluations
of diaTepam
arc treated orally
the patient the patients
should
becomes
should
continue.
up IO every
bc
and if
6 h. should
loading dose. very few patients require
relatively
symptoms.
administration
in nauseated patients.
Chlordia/.epoxidr
at
be
additional
seekinc c bcbavior. Because dia/epam and it\ active have long half-lives (33 and 50 h on average. respectively),
of withdrawal
dia7epam. although
25
(7 drug
desmethyldiazepam.
regimen
increase in severity.
Patients
are suppressed
reduced following
Once treated with the initial
thereby
metaholite.
until
need
subside.
by NAKANJO et trl. ( 19%).
is not sufficiently
co-existing
reappear.
administered.
hour
trequently
and ct’fectively trcatctl according to a dia/epam
can be safely
described
States
may offer
IO mg or oral chlordia/.epoxide
until either the symptoms
Patients
one
The
delirium
and
withdrawal.
mg every 0 h as required may be administered
loading
withdrawal.
seizures
available for clinical
Patients
over other drugs
of alcohol
and treat withdrawal
in the treatment
advantages over another in specific
of benLodia/.epincs
in the treatment
be used to prevent
the benxodiazepines
all appear to be equally only minimal
the superiority
and hydroxy/ine
Dia;lepam
has a duration
free of drug-induced
is also available
of action
md
it is absorbed more slowly.
“high”
a\ an intravenous
metabolic pathway roughly A similar
regimen
md
rc-emergence
preparation similar
as descrihcd
for rapid to that of
for, dia/.epam.
BEMODIAZEPINES
AND
123
ALCOHOL
however, can be followed using chlordiazepoxide 2.5 mg instead of diazepam 10 mg. Oxazepam and lorazepam have shorter half-lives (8 h and 10 h on average, respectively) than diazepam and chlordiazepoxide, and should therefore be administered every 6 h (oxazepam 15-60 mg, lorazepam 1-3 mg). Tapering of either lorazepam or oxazepam should begin on the second day, decreasing approximately lS-25% from the initial daily dose every day. Tapering should be accomplished by decreasing the dose, not by increasing the interval between doses. Lorazepam may also be administered intra-muscularly or sub-lingually in nauseated patients. The benzodiazepines have similar side effects. Memory impairment is common, although often subtle. Impairment will frequently be sufficiently severe, however, to interfere with rehabilitation attempted during the first several days of hospitalization. Minor cardiovascular and respiratory depression may occur with high doses, although this is unusual when benzodiazepines are administered alone. Because they have an additive interaction in combination with ethanol, caution must be exerted when benzodiazepines are administered for the treatment of ethanol withdrawal before the blood alcohol concentration reaches zero. Diazepam has been reported to inhibit the gag reflex, thus increasing the risk of aspiration in nauseated patients. Symptoms of benzodiazepine overdose such as excessive drowsiness. lethargy, alaxia, diplopia, and confusion are similar to those observed with ethanol intoxication. USE OF BENZODIAZEPINES
IN TREATMENT
OF PATIENTS
WITH ALCOHOL
DEPENDENCE
Diagnostic considerutions Adoption studies by CLONINGERet al. (1988) have defined two genetically distinct forms of alcoholism called Type I and Type II. Type 1 is the more common form of the illness. It affected 75% of men alcoholics and all women alcoholics in the sample investigated. For the genetic predisposition to be expressed, a man who is at risk needs to be exposed to an adverse environment. Women may express the gene effect also without environmental provocation. Type II alcoholism afflicts only men. Approximately 25% of alcoholic men have this disorder. It is inherited from fathers to sons, but not to daughters, and the gene effect is expressed without environmental provocation. Excessive consumption of alcohol starts at an early age and anti-social personality disorder and criminality co-exist with alcoholism in the families. Women with the genetic background often have symptoms of somatization. Patients with Type II alcoholism are unlikely to benefit from benzodiazepines. Indeed, these drugs are relatively contraindicated in such patients, particularly if they exhibit impulsive behaviors, which may be aggravated by benzodiazepines. If psychotropics are indicated in Type II alcoholics to treat symptoms such as poor impulse control and dysthymia, medications such as carbamazepine and lithium probably are preferable. However, no controlled studies are available on pharmacological treatment of Type II alcoholism with or without other mental disorders. Type I alcoholics free of other mental disorders may not benefit from any pharmacotherapy. Patients with Type I alcoholism who exhibit symptoms or have a history of other mental disorders should be divided into primary and secondary alcoholics depending on the relative times of onset of alcoholism and other mental disorders. Patients with primary Type I alcoholism and secondary mental disorder other than alcoholism need to maintain abstinence, and the secondary mental disorder needs to be treated vigorously. Successful treatment of
alcoholism
as such may reduce
Patients
with
treatment
secondary
of the primary
mental
The issue of alcoholics in choosing
to be actively
block
therapeutically
Anxiety.
and
pharmacotherapy
and than
of anxiety
attacks.
alcohol
alcoholism
with
hut
needs to be considered and
abstinence alcohol
may
disorders
are
more
of the population. on a careful
common
The
among
approach
differential
to the
diagnosis
of
because
treatment
of panic
for
panic
alcoholics
patients
relationship
disorder
well
with
between
associated
have
v, ith panic
reported
are probably
to tricyclic
I .3 benzodin/-epines
of the rccenlly patient
amine
mild additive adverse
following
among
than the
panic
panic
attacks
attacks
and
been thought
attacks.
efficacies
monoamine
~triti-deprcs~lrnts
and
to be effective
onlv
111
thi5 concept
may
hc
However.
of clonazcpam
oxida\c
(TCA\)
and
lora~epam
in the
attack:s.
then secondary
beverages
The
alw respond
anxiety
If an alci)hol-deperldent
inhibitor\.
common
may he that certain
anxiety.
of choice
patients
anticipatory
are more
explanation
be complex.
The conventional
changing
‘WA\
eff’ects
M ith panic
bvith alcohol
the;< do not produce should
attack\
are probably
on psychomotor
cstastrophiz
an alcoholic
is dctcrmincd
the treatment
rc!apse
with
g during
to pre\ent
a suicide
tlmp
Thcye
performance.
interactions lo drinkin
not
oi‘choicc.
have oni)
Furthermore.
tyraminc drug
unlike
containing
treatment
food4
and
\top
dic1 res(rictions.
According trestmcnt
to preliminary
of panic
in heav!
thev. mav. become
phobia\ treatment
pharniacotherapy. be avoided
not produce
reup:akc
drinking
they
behavioral
serotonin
These drugs do not product
bnsi\.
Social
reduce
reports.
disorder.
Thu\.
difficulty
The
to drinking.
of psychotropics.
deficit depends
disorder.
to encourage
use of psychotropics
the rest
agoraphobia.
anticipatory
the treamientb
inhibitors,
alleviating
should
mental
the risk of relapse
measures
effects
attention
The simplest
may, however.
alpra/olam.
and
concomitant
among
disorder.
to medications
Furthermore.
in alcoholics
and without
to alleviate
In general. (MAO)
MAO
to reduce
risk of addiction
pharmacological
families
mental
for the primary
disorders.
Panic
risk.
is expected
because
affective.
rest of the population. drink
at a high
be treated
pharmacotherapy.
necessary
their
of the secondary
should
disorder
promoted,
eating.
alcoholics anxiety
being
appropriate
need
symptoms
alcoholism
can
\(lcial
the :reatment
bc ~ucce~~t‘~~lIy
program In patients
involvin with
drinkers.
of choice
treated
alcoholism
dependence. in maintaining
If beta-blockers \obricty,
a drug.
with
hcta-blocker\
mav
be effective
and
social
dependcncc. are
LISU~